Picture of Abliva AB logo

ABLI Abliva AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Abliva AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-77.1-60.1-123-83.2-96.5
Depreciation
Non-Cash Items0.1210.1070.5121.049.78
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital2.16-10.26.24-8077.1
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-72.4-67.6-114-160-7.8
Capital Expenditures-2.69-1.41-1.09-0.905-1.29
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0
Other Investing Cash Flow
Cash from Investing Activities-2.69-1.41-1.09-0.905-1.29
Financing Cash Flow Items0.01624.20
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities10772.375.82040.414
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash32.43.32-39.344.1-8.73